| Name | Title | Contact Details |
|---|
Meridian Healthcare provides high quality care and services to older people in the UK. With care centres spread across the North of England, Meridian cares for over 1400 residents and many more day care clients. In our annual Customer Satisfaction Survey, well over 95% of families are keen to point out that they would recommend us for respite and long term care. We provide nursing, residential and specialist dementia care as well as day care services. Our residents may fund themselves or be funded wholly or partly by their local authorty. Our staff are well trained and undergo a range of mandatory and complementary training programmes ranging from Manual Handling and First Aid through to development programmes for our Managers. We pride ourselves on our training approach which has led to well over 90% of our staff being trained or in the process of training for appropriate NVQ levels.
PaloDEx Group Oy operates in the international healthcare market, focusing on X-ray technology applications used in dental imaging. By offering high-quality imaging solutions that help in making the correct treatment decisions and in improving the level
TMC Orthopedic is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Conroe, TX. To find more information about TMC Orthopedic, please visit www.tmcortho.com
Hi Care Management is a Springfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.